Putnam Investments LLC Global Blood Therapeutics, Inc. Transaction History

Putnam Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $1.97 Million - $3.33 Million	-52,227 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $95,337 - $134,603	1,807 Added 3.58%	52,227 $2.88 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $410,940 - $689,988	8,433 Added 20.08%	50,420 $3.18 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $808,325 - $1.69 Million	-19,375 Reduced 31.57%	41,987 $2.15 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $5,396 - $6,891	119 Added 0.19%	61,362 $2.98 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1,683 - $2,025	32 Added 0.05%	61,243 $3.22 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $153,568 - $227,236	4,869 Added 8.64%	61,211 $2.51 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $1.42 Million - $1.92 Million	37,498 Added 198.99%	56,342 $2.14 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $116,022 - $150,349	-2,998 Reduced 13.73%	18,844 $852,000
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $864,943 - $1.44 Million	21,842 New	21,842 $1.06 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.